Tokyo, Japan

Masanori Morita

This inventor holds 10 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignees: Seiko Epson Corporation, Ntt Docomo, Inc., The Green Cross Corporation. Active years: 1992-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masanori Morita. Retrieved from https://idiyas.com/inventor/masanori-morita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 50.0

 

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 48(Granted Patents)


Location History:

  • Osaka, JP (1992)
  • Hirakata, JP (1995)
  • Tachikawa, JP (2009 - 2010)
  • Fussa, JP (2008 - 2016)
  • Tokyo, JP (2005 - 2019)

Company Filing History:


Years Active: 1992-2019

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations by Masanori Morita in Human Prourokinase

Introduction

Masanori Morita, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of biotechnology. With a total of two patents registered under his name, Morita's work primarily focuses on improving the therapeutic applications of human prourokinase, an important enzyme in the fibrinolytic system.

Latest Patents

Masanori Morita's latest patents include innovative approaches to mutant human prourokinase. The first patent details a mutant human prourokinase wherein a neutral amino acid in the epidermal growth factor (EGF) region is exchanged with either a basic or a non-acidic amino acid. This alteration aims to enhance the stability of the enzyme in the bloodstream, thus prolonging its half-life and improving its affinity for fibrin.

The second patent outlines the creation of a human prourokinase mutant, characterized by the deletion or alteration of portions of the epidermal growth factor domain. The modifications are designed to retain the enzyme's activity while extending its blood half-life beyond that of the naturally occurring variant. Specifically, it mentions the modification of regions such as the segment from asparagine to cysteine and others.

Career Highlights

Throughout his career, Masanori Morita has worked at The Green Cross Corporation, a firm renowned for its advancements in biopharmaceuticals. His expertise in enzymology and modifications of biochemical compounds has positioned him as a key innovator within the company. Morita's contributions have paved the way for potential new therapies in the treatment of various medical conditions involving clotting.

Collaborations

Masanori Morita has collaborated with other notable professionals in his field, including Toshizumi Tanabe and Yasuo Amatsuji. Together, they have focused on pioneering research to develop more effective therapeutic solutions based on the unique properties of human prourokinase.

Conclusion

Masanori Morita's innovative work on human prourokinase demonstrates the vital role of inventors in advancing scientific knowledge and developing new medical treatments. His patents not only reflect his dedication to research but also highlight the potential of biotechnology in improving patient care. As an inventor, Morita continues to inspire and contribute to the scientific community with his groundbreaking inventions in biopharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…